JCS/T2D JCS/T2D
JCS/T2D JCS/T2D
  • Home
  • About
  • Disclaimer
  • Privacy
  • Search
  • Contact Us
  • Addressing Misconceptions: A Closer Look at Weight Loss Drugs and Their Role in Managing Obesity and Type 2 Diabetes

  • Eli Lilly's Stance on Tirzepatide for Cosmetic Use

  • Lifestyle Changes and Anti-Obesity Medications: A Complementary Approach

  • Mounjaro Shortage: A Challenge for Diabetes and Obesity Patients

  • Mounjaro Shows Heart Health Potential in Landmark Diabetes Trial

  • Mounjaro: A New Player in the GLP-1 Arena for Type 2 Diabetes Management

  • The Economic Impact of Weight-Loss Drugs: A Trillion-Dollar Boost?

  • Wegovy Outperforms Mounjaro in Cardiovascular Outcomes

  • You are here:  
  • Home
  • Tags
  • Mounjaro
 

JCS/T2D

We are advocates. We learn. We share. We inform.
Bringing clarity to type 2 diabetes, obesity care, health research, and the data behind them.

Content is provided for educational and informational purposes and is not medical advice.

Helpful Links

About Us
Contact Us
JCS Analytics

Copyright © 2026 JCS/T2D - A Diabetes Journey. All Rights Reserved.
Joomla! is Free Software released under the GNU General Public License.